These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 34218990)
1. Initial treatment of diabetes in Italy. A nationwide population-based study from of the ARNO Diabetes Observatory. Bonora E; Cataudella S; Marchesini G; Miccoli R; Vaccaro O; Fadini GP; Martini N; Rossi E; Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2661-2668. PubMed ID: 34218990 [TBL] [Abstract][Full Text] [Related]
2. Incidence of diabetes mellitus in Italy in year 2018. A nationwide population-based study of the ARNO Diabetes Observatory. Bonora E; Cataudella S; Marchesini G; Miccoli R; Vaccaro O; Fadini GP; Martini N; Rossi E; Nutr Metab Cardiovasc Dis; 2021 Jul; 31(8):2338-2344. PubMed ID: 34074587 [TBL] [Abstract][Full Text] [Related]
3. Incidence, prevalence, costs and quality of care of type 1 diabetes in Italy, age 0-29 years: The population-based CINECA-SID ARNO Observatory, 2002-2012. Bruno G; Pagano E; Rossi E; Cataudella S; De Rosa M; Marchesini G; Miccoli R; Vaccaro O; Bonora E Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1104-1111. PubMed ID: 27817991 [TBL] [Abstract][Full Text] [Related]
4. The prevalence and treatment patterns of diabetes in the Greek population based on real-world data from the nation-wide prescription database. Liatis S; Dafoulas GE; Kani C; Politi A; Litsa P; Sfikakis PP; Makrilakis K Diabetes Res Clin Pract; 2016 Aug; 118():162-7. PubMed ID: 27372056 [TBL] [Abstract][Full Text] [Related]
5. Outcomes and treatment patterns of adding a third agent to 2 OADs in patients with type 2 diabetes. Levin PA; Wei W; Zhou S; Xie L; Baser O J Manag Care Spec Pharm; 2014 May; 20(5):501-12. PubMed ID: 24761822 [TBL] [Abstract][Full Text] [Related]
6. Patterns of initial and first-intensifying antidiabetic drug utilization among patients with type 2 diabetes mellitus in Scotland, 2010-2020: A retrospective population-based cohort study. Mahmoud F; Mueller T; Mullen A; Sainsbury C; Rushworth GF; Kurdi A Diabetes Obes Metab; 2024 Jul; 26(7):2684-2694. PubMed ID: 38558305 [TBL] [Abstract][Full Text] [Related]
7. Approaches to treatment 1: How is type 2 diabetes actually treated? Bloomgarden ZT J Diabetes; 2015 Nov; 7(6):747-8. PubMed ID: 26211568 [No Abstract] [Full Text] [Related]
8. Initial therapy, persistence and regimen change in a cohort of newly treated type 2 diabetes patients. Grimes RT; Bennett K; Tilson L; Usher C; Smith SM; Henman MC Br J Clin Pharmacol; 2015 Jun; 79(6):1000-9. PubMed ID: 25521800 [TBL] [Abstract][Full Text] [Related]
9. Patterns of anti-diabetic medication use in patients with type 2 diabetes mellitus in England and Wales. Datta-Nemdharry P; Thomson A; Beynon J; Donegan K Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):127-135. PubMed ID: 27642000 [TBL] [Abstract][Full Text] [Related]
10. Employing observational method for prospective data collection: A case study for analyzing diagnostic process and evaluating efficacy of TCM treatments for diabetes mellitus. Gu X; Huang N; Gu J; Joshi MK; Wang H J Ethnopharmacol; 2016 Nov; 192():516-523. PubMed ID: 27616025 [TBL] [Abstract][Full Text] [Related]
12. Treatment Patterns in Patients With Newly Diagnosed Type 2 Diabetes in China: A Retrospective, Longitudinal Database Study. Wang C; Gao Y; Zhu L; Huang M; Wu Y; Xuan J Clin Ther; 2019 Aug; 41(8):1440-1452. PubMed ID: 31155146 [TBL] [Abstract][Full Text] [Related]
13. Treatment persistence in the use of basal insulins in Poland and Germany . Rathmann W; Czech M; Franek E; Kostev K Int J Clin Pharmacol Ther; 2017 Feb; 55(2):119-125. PubMed ID: 27879196 [TBL] [Abstract][Full Text] [Related]
14. Temporal trends in the initiation of glucose-lowering medications after a first-time myocardial infarction - a nationwide study between 1997 and 2006. Norgaard ML; Andersson C; Hansen PR; Andersen SS; Vaag A; Schramm TK; Folke F; Køber L; Torp-Pedersen C; Gislason GH Cardiovasc Diabetol; 2011 Jan; 10():5. PubMed ID: 21247456 [TBL] [Abstract][Full Text] [Related]
15. Changes in time to insulin initiation in type 2 diabetes patients: a retrospective database analysis in Germany and UK (2005-2010). Kostev K; Rathmann W Prim Care Diabetes; 2013 Oct; 7(3):229-33. PubMed ID: 23608219 [TBL] [Abstract][Full Text] [Related]
16. Changing Patterns of Glucose-Lowering Medication Use in VA Nursing Home Residents With Diabetes, 2005 to 2011. Lee SJ; Stijacic-Cenzer I; Barnhart C; McClymont K; Steinman MA J Am Med Dir Assoc; 2015 Oct; 16(10):898.e9-14. PubMed ID: 26272298 [TBL] [Abstract][Full Text] [Related]
17. Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis. Filion KB; Joseph L; Boivin JF; Suissa S; Brophy JM Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):973-6. PubMed ID: 19621344 [TBL] [Abstract][Full Text] [Related]
18. GLUCAGON PRESCRIPTION PATTERNS IN PATIENTS WITH EITHER TYPE 1 OR 2 DIABETES WITH NEWLY PRESCRIBED INSULIN. Mitchell BD; He X; Sturdy IM; Cagle AP; Settles JA Endocr Pract; 2016 Feb; 22(2):123-35. PubMed ID: 26484405 [TBL] [Abstract][Full Text] [Related]
19. Sex Differences in Cardiovascular Effectiveness of Newer Glucose-Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus. Raparelli V; Elharram M; Moura CS; Abrahamowicz M; Bernatsky S; Behlouli H; Pilote L J Am Heart Assoc; 2020 Jan; 9(1):e012940. PubMed ID: 31902326 [TBL] [Abstract][Full Text] [Related]
20. Changing use of antidiabetic drugs in the UK: trends in prescribing 2000-2017. Wilkinson S; Douglas I; Stirnadel-Farrant H; Fogarty D; Pokrajac A; Smeeth L; Tomlinson L BMJ Open; 2018 Jul; 8(7):e022768. PubMed ID: 30056393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]